ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

The National Health Council has launched a Detroit pilot campaign [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Medicus Pharma has received authorisation from the UAE Department of [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]